TY - JOUR A1 - Degro, Claudius E. A1 - Strozynski, Richard A1 - Loch, Florian N. A1 - Schineis, Christian A1 - Speichinger, Fiona A1 - Lee, Lucas D. A1 - Margonis, Georgios A. A1 - Lauscher, Johannes C. A1 - Beyer, Katharina A1 - Kreis, Martin E. A1 - Kamphues, Carsten T1 - Survival rates and prognostic factors in right- and left-sided colon cancer stage I–IV: an unselected retrospective single-center trial T2 - International Journal of Colorectal Disease N2 - Purpose Colorectal cancer revealed over the last decades a remarkable shift with an increasing proportion of a right- compared to a left-sided tumor location. In the current study, we aimed to disclose clinicopathological differences between right- and left-sided colon cancer (rCC and lCC) with respect to mortality and outcome predictors. Methods In total, 417 patients with colon cancer stage I–IV were analyzed in the present retrospective single-center study. Survival rates were assessed using the Kaplan–Meier method and uni/multivariate analyses were performed with a Cox proportional hazards regression model. Results Our study showed no significant difference of the overall survival between rCC and lCC stage I–IV ( p = 0.354). Multivariate analysis revealed in the rCC cohort the worst outcome for ASA (American Society of Anesthesiologists) score IV patients (hazard ratio [HR]: 16.0; CI 95%: 2.1–123.5), CEA (carcinoembryonic antigen) blood level > 100 µg/l (HR: 3.3; CI 95%: 1.2–9.0), increased lymph node ratio of 0.6–1.0 (HR: 5.3; CI 95%: 1.7–16.1), and grade 4 tumors (G4) (HR: 120.6; CI 95%: 6.7–2179.6) whereas in the lCC population, ASA score IV (HR: 8.9; CI 95%: 0.9–91.9), CEA blood level 20.1–100 µg/l (HR: 5.4; CI 95%: 2.4–12.4), conversion to laparotomy (HR: 14.1; CI 95%: 4.0–49.0), and severe surgical complications (Clavien-Dindo III–IV) (HR: 2.9; CI 95%: 1.5–5.5) were identified as predictors of a diminished overall survival. Conclusion Laterality disclosed no significant effect on the overall prognosis of colon cancer patients. However, group differences and distinct survival predictors could be identified in rCC and lCC patients. Y1 - 2021 UR - https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/123830 UR - https://nbn-resolving.org/urn:nbn:de:bvb:384-opus4-1238308 SN - 0179-1958 SN - 1432-1262 VL - 36 IS - 12 SP - 2683 EP - 2696 PB - Springer Science and Business Media LLC ER -